BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 8, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory actions for Aug. 17, 2020

Aug. 17, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter.
Read More

Other news to note for Aug. 17, 2020

Aug. 17, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiodynamics, Anthem, Avateramedical, Brain Scientific, Carterra, Endospan, Forwardttc, Genmark Diagnostics, Hengrui Therapeutics, Magle Chemoswed, Microbot Medical, Quest Diagnostics, Sectra, Sirtex Medical, Swift Biosciences, Thermo Fisher Scientific, Tissue Regenix Group, Todos Medica.
Read More
Coronavirus microscopic model

CNBG unveils interim data of inactivated vaccine candidate for COVID-19

Aug. 17, 2020
By Elise Mak
Chinese state-backed vaccine developer China National Biotec Group (CNBG), of Beijing, published an interim analysis of randomized phase I/II trials of its inactivated SARS-CoV-2 vaccine candidate in the Journal of the American Medical Association last week.
Read More
R&D money

Biopharmas continue to ramp up their R&D investments, analysis finds

Aug. 17, 2020
By Peter Winter
According to an analysis conducted by BioWorld of the second-quarter 2020 financial reports filed by 120 public biopharmaceutical companies with market caps greater than $1 billion, and excluding big pharma companies, the amount that was invested in research and development during the period increased by 14% compared to the same six-month period last year.
Read More

ICYMI: Week in Review, Aug. 10-14, 2020

Aug. 17, 2020
By Peter Winter
A quick look back at top stories.
Read More

Regulatory front for Aug. 17, 2020

Aug. 17, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Other news to note for Aug. 17, 2020

Aug. 17, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abeona, Adgero, Aicuris, Alnylam, Arvelle, Bioaegis, BMS, Bold, Boundless Bio, Carsgen, Dragonfly, Delmar, Enzon, Hengrui, Hifibio, Kiadis, Memo, Organovo, Ose, Pluristem, Taysha, Thermo Fisher, Xbiotech.
Read More

In the clinic for Aug. 17, 2020

Aug. 17, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Amplyx, Ansun, Ascletis, Axcella, Azurrx, Betagenon/Balticgruppen, Chiasma, Clovis, Enterprise, GNI Group, I-Mab, Merck, Neuroptika, Novavax, Precigen, Syndax, Unity.
Read More

Regulatory actions for Aug. 14, 2020

Aug. 17, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Kempharm, Mesoblast, TLC, Verona.
Read More

European Commission’s first COVID-19 deal goes to Astrazeneca while Novavax signs U.K agreement

Aug. 14, 2020
By Lee Landenberger
Astrazeneca plc is the first company to sign an agreement with the European Commission to supply a COVID-19 vaccine.
Read More
Previous 1 2 … 392 393 394 395 396 397 398 399 400 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 5, 2026.
  • New York University identifies new analogues of mannose-6-phosphate

    BioWorld Science
    New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
  • China compass

    ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

    BioWorld
    If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
  • Bial-Portela discovers new OX1 receptor antagonists

    BioWorld Science
    Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
  • Liver disease

    FB-7033 demonstrates efficacy in MASH management

    BioWorld Science
    17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing